Omnicell Inc
SWB:OC9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Omnicell Inc
SWB:OC9
|
US |
|
Happy Valley Nutrition Ltd
ASX:HVM
|
NZ |
|
Inventiva SA
NASDAQ:IVA
|
FR |
|
S1 Corp
KRX:012750
|
KR |
|
N
|
Nusa Raya Cipta Tbk PT
IDX:NRCA
|
ID |
|
Bucher Industries AG
SIX:BUCN
|
CH |
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
OTC:AIQUY
|
FR |
|
Burberry Group PLC
LSE:BRBY
|
UK |
|
Magna International Inc
TSX:MG
|
CA |
Wall St Price Targets
OC9 Price Targets Summary
Omnicell Inc
According to Wall Street analysts, the average 1-year price target for OC9 is 54.08 EUR with a low forecast of 48.06 EUR and a high forecast of 63.59 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OC9's stock price target?
Price Target
54.08
EUR
According to Wall Street analysts, the average 1-year price target for OC9 is 54.08 EUR with a low forecast of 48.06 EUR and a high forecast of 63.59 EUR.
What is the Revenue forecast for Omnicell Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 6%.
What is the Operating Income forecast for Omnicell Inc?
Projected CAGR
124%
Over the last 13 years, the compound annual growth rate for Operating Income has been -6%. The projected CAGR for the next 3 years is 124%.
What is the Net Income forecast for Omnicell Inc?
Projected CAGR
273%
Over the last 13 years, the compound annual growth rate for Net Income has been -15%. The projected CAGR for the next 3 years is 273%.
